methylene blue has been researched along with lypressin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, JA; Bihari, D; Cranney, GB; Galhenage, S; Kim, R; Liu, J; Riordan, SM; Thomas, PS; Wegner, EA | 1 |
| Belletti, A; Finco, G; Fominskiy, E; Hajjar, LA; Landoni, G; Monaco, F; Musu, M; Pasin, L; Saleh, O; Silvetti, S; Zangrillo, A | 1 |
1 review(s) available for methylene blue and lypressin
| Article | Year |
|---|---|
Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials.
Topics: Databases, Factual; Humans; Lypressin; Methylene Blue; Randomized Controlled Trials as Topic; Sepsis; Shock; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2015 |
1 other study(ies) available for methylene blue and lypressin
| Article | Year |
|---|---|
Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome.
Topics: Antihypertensive Agents; Blood Pressure; Chronic Disease; Curcumin; Cyclic GMP; Echocardiography; Female; Hepatopulmonary Syndrome; Humans; Lypressin; Methylene Blue; Middle Aged; Nitric Oxide; Terlipressin; Treatment Failure; Vascular Resistance | 2007 |